Healix

Clinical and Economic Outcomes of Outpatient Parenteral Antimicrobial Therapy (OPAT) Among Indigent Patients: A Retrospective Multicenter Analysis

Authors:
Brian S. Metzger, MD, MPH – Austin Infectious Disease Consultants, Austin, TX
Richard M. Mandel, MD – Southern Arizona Infectious Disease Specialists, Tucson, AZ
Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Inc., Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound